Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-BROMOPHENYL)-1,2-DIHYDRO-5H-TETRAZOL-5-ONE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

98556-14-0

Post Buying Request

98556-14-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

98556-14-0 Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

This describes the arrangement of atoms and the type of chemical bonds in the compound.
3. Tetrazole derivative

Explanation

The compound is derived from the tetrazole ring, which is a five-membered ring containing four nitrogen atoms and one non-aromatic carbon atom.
4. Bromophenyl group

Explanation

The compound contains a bromine atom attached to a phenyl group, which is a six-carbon aromatic ring.
5. Potential pharmaceutical applications

Explanation

The compound has been studied for its possible use in the development of drugs, particularly as an antimicrobial and antitumor agent.
6. Antimicrobial activity

Explanation

The compound may have the ability to inhibit the growth of or kill microorganisms, making it a potential candidate for use in treating infections.
7. Antitumor activity

Explanation

The compound may have the potential to inhibit the growth of tumors or cancer cells, making it a potential candidate for use in cancer treatment.
8. Synthesis of other organic compounds

Explanation

The compound can be used as a starting material or intermediate in the synthesis of other organic compounds, which may have various applications.
9. Biological activities

Explanation

As a tetrazole derivative, the compound may exhibit various biological activities, making it a subject of interest for further research and investigation.
10. Therapeutic uses

Explanation

The compound may have potential therapeutic applications, such as in the treatment of infections or cancer, based on its antimicrobial and antitumor properties.

Structure

1-(4-Bromophenyl)-1,2-dihydro-5H-tetrazol-5-one

Check Digit Verification of cas no

The CAS Registry Mumber 98556-14-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,5,5 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 98556-14:
(7*9)+(6*8)+(5*5)+(4*5)+(3*6)+(2*1)+(1*4)=180
180 % 10 = 0
So 98556-14-0 is a valid CAS Registry Number.

98556-14-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromophenyl)-2H-tetrazol-5-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:98556-14-0 SDS

98556-14-0Upstream product

98556-14-0Downstream Products

98556-14-0Relevant academic research and scientific papers

TRIAZOLONES AND TETRAZOLONES AS INHIBITORS OF ROCK

-

Page/Page column 82; 83, (2017/12/29)

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

PDE 10a Inhibitors for the Treatment of Type II Diabetes

-

Paragraph 0537-0539, (2015/01/06)

Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R1, R2, L, and Q are defined herein.

PDE 10a Inhibitors for the Treatment of Type II Diabetes

-

Paragraph 0826; 0827, (2015/01/06)

Disclosed are compounds, compositions and methods for treating Type II diabetes. Such compounds are represented by Formula (I) as follows: wherein R1, R2, L, and Q are defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 98556-14-0